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Which procedure is the best?
Growing uncertainty over role and value of PCI in Multivessel
and/or Left Main
Outcomes (↑ mortality, ↑ reintervention, ↑ risks with DES) •
Are patients adequately informed of the risks and limitations 
of PCI to allow informed consent?
Fergusson Lecture at STS 2006 ATS 2006; 82: 1966-76 •www.sts.org
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• Aim today is to update that lecture and focus on the key issues
• 1. Evidence basis for LEFT MAIN stenosis- PCI v.s. CABG 
• 2. Evidence basis (absence of ?) for PCI with and without stents
• 3. Cost effectiveness of CABG vs PCI
• 4. Appropriateness of cardiology guidelines for PCI ?
• 5. What information is given to patients and by whom
Fergusson Lecture at STS 2006 ATS 
2006; 82: 1966-76 •www.sts.org
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EVIDENCE BASIS FOR CABG:STRONG SCIENTIFIC 
RATIONALE 
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Question
WHY DOES CABG HAVE SUCH A SURVIVAL BENEFIT OVER PCI ?
• CABG TREATS BOTH THE „CULPRIT CULPRIT‟LESION AND FUTURE 
CULPRIT LESION(S), OF ANY COMPLEXITY •
• Patients with CAD have diffusely unstable coronary endothelium
• CABG places grafts to mid vessel thereby protecting whole zones of vulnerable 
proximal myocardium against culprit and „de novo‟ lesions
• PCI only deals with „suitable‟ localised proximal culprit lesions and has no 
prophylactic benefit against new disease
• PCI is unlikely to ever match the results of CABG for LM/MVD
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“There is no survival difference between CABG and PCI”
The most widely perpetuated myth in cardiovascular medicine 
“The great enemy of the truth is very often not the lie –
deliberate, contrived and dishonest –but the myth –
persistent, persuasive and unrealistic.”John F Kennedy.
Based on 15 RCT where results were stacked against CABG 
Ignoring consistently strong data from numerous large 
databases which demonstrate survival benefit of CABG
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What is the Scale of the Problem with Stent Thrombosis in Over Six million 
Implanted Drug Eluting Stents?
Universally agreed there is a problem but scale uncertain because of   
limited duration and completeness of follow-up 
FDA (Dec 2006) accept ↑ risk of thrombosis with „off-label‟ use
Thrombosis can occur even on two antiplatelets but highest risk if 
•one or both antiplatelets stopped 
•„Off Label‟ Lesions (long/multiple/overlapping/ bifurcation)=80% 
Patients (elderly, diabetes, ACS, low EF, renal failure)
AHA/ACC recommend aspirin + clopidogrel for > one year (JACC 2007)  
Bleeding risks 
Cost of clopidogrel ($ 1400/year)
„Debating the risks of drug eluting stents‟ Shuchman NEJM 24 Jan 2007
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Summary for CABG vs PCI in stable multivessel CAD
• For CABG there is consistently strong evidence from databases of >80,000 patients of a significant 
survival benefit and a marked decrease in the need for reintervention
• FOR PCI 
• There is no evidence from RCT to support its use in multivessel disease (as these patients were excluded 
from RCT) 
• All available evidence from large databases show that PCI impairs survival vs CABG and ↑ 
reintervention by X7 
• Meta-analyses of PCI vs medical therapy show 
• No improvement in survival 
• No reduction in myocardial infarction 
• No reduction in repeat intervention (? ↑) 
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ACC/AHA Guidelines for ACBP 2004
Class I:
-LMN 50%
-LMN equivalent with 70% LAD and LCx proximal stenosis
-Multivessel dissease low ejection fraction
-Proximal LAD stenosis with low ejection fraction
Cost-benefit from stenting
1. Myocardial infarction?
2. Unstabile coronary syndrom
3. Shock cardiogenes
4. Stenting and multivessel dissease ????
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Why is PCI replacing CABG against all the available evidence?
• Califf RM. Stenting or Surgery JACC 2005; 46: 589 589-91 :
• “It is likely that most people undergoing coronary angiography are not told the 
entire story when a decision is made about undergoing PCI … self-referral.. 
financial incentives ..without surgical opinion the patient is in no position to have 
rational input into the decision”
Decision depends from patients 
information 
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“patients do not want operations”
- No one wants any operation
- Patient’s decision on CABG depends who presents 
information and its balanceno patient wants ‘cracking the 
chest’ if the same effect can be achieved with PCI
- But most patients want the best treatment and many will 
accept an operation if it increases survival by 5% (or 
reduces risk of mortality by 1/3) within 3-5 years
and allows them to get on with life without repeat interventions 
and the worry of ‘failed stents’
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Questions
Do you agree with the authors of the SYNTAX trial 
that CABG should be the standard of care?
•Yes 57%
•No 43%
Will the SYNTAX results change the advice you give
your patients about the choice of treatments?
•Yes 54%
•No 46%
Poll Closed Mar. 4, 2009
( total responses 28 543 )
What every surgeon should be able to tell their cardiologists about 
CABG v.s. Stents for CAD !!!!!
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Surgical techniques
• - CABG with EKC
• - CABG with EKC without cardioplegy
• - CABG in off-pump conditions
• - CABG for ischemic heart failure
Type of grafts
• LIMA; RIMA
• Vena saphena magna
• Radial artery
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Aorto-coronary by-pass n = 5142 pts
CABG + IABP pre -op. 252pts
CABG + IABP intra-op. 82pts
CABG + IABP post-op. 45pts
CABG 5142 62,5%
OPCAB 745 14,5%
Total arerial revasc. 2894 56.3%
CABG+aneurysmetoy 740 14.4%
CABG + valv surgery 763 15.3%
120 pts with haemodynamis instability- acute 
coronary syndrom
Mortality rate 1,2%    - 61 pts.
Follow – up > 10 y.
-
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Off pump bypass – OPCAB n = 745 pts
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Cardiosurgery -
Surgery  for patients with terminal ishemic heart-
ventriculoplasty &by-pass surgery N-740 (14,4%)
Direct circular repair for anterior left ventricle aneurysm N=433pts
Haemodinamic parameters:
EDV=345  33.4ml      EF=27  6.2%
ESV= 259  26.5ml    Mortality rate -5,6 (21 pts)
Surgery- ventriculoplasty with posterior cuneate or separate 
posterior linear reconstruction  N=96 pts
Haemodinamic parameters:
EDV=367  23.5ml      EF=25  5.6%
ESV= 299  22.4ml  Mortality rate  4 (5,6) % pts
Transventricular mitral valve reconstruction for pts with LV
aneurysm and mitral valve insuff N=56pts
EDV=367  23.5ml      EF=25  5.6%
ESV= 299  22.4ml  Mortality rate 4 (8,6 %) pts
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Surgery for patients in cardiogenic shock and   
postinfarction VSD         
Haemodinamic stabilisation
Pre-operative IABP 5 
Cathecholemines if necessery
Postinfarction VSD - 5 (6%) 
Strategy - IABP, 
- haemodynamic stabilisation
- operation
Haemodynamic parameters:
EDV=232  30.4ml      EF=25  4.2%
ESV= 189  28.5ml
Early mortality rate 0
Late mortality rate 1 pts
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Surgery – OPCAB left ventricle plication (n=37pts) 
52  6.4y  Sex f/m  20/17
Heamodinamic instability 2 (6%) pts
Pre-operative IABP 4(12%) pts
Post-operative IABP 0
Haemodinamic parameters:
EDV=250  13.7ml      EF=30  4.8%
ESV= 169  19.4ml
Prezented on X Jubillee congress 
CTT/ Mayami 03/2004 year
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Coronary Artery Bypass Grafting in Awake 
Settings
Awarded on the 6th annual meeting of ISMICS in San 
Francisco (06/2003) as the best oral abstract and the 
best use of audio and video aims
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Complications rate N= 5142
Early survival (30 days)   98.8%
SyntaxEnd – point Our experiences 
(%)
MACCE 8,9
Death/MI/stroke 4,5
Revascularisatio
n
0,19
Stroke 1,6
MI 2,4
All-cause death 1,2
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Mortality rate                             N = 8217
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